How fast-moving consumer goods companies in Switzerland offer better alternatives helping customers make better consumption choices in their everyday lives.
The Swiss public has learnt – involuntarily – a lot about infectious diseases in the past year due to COVID-19. Understandably, public attention and resources have been focused on getting through the pandemic.
In the shadow of this focus on infectious diseases, however, a group of non-infectious diseases – termed noncommunicable diseases (NCDs) – has continued to put significant strain on the healthcare system. In fact, the main indicators of NCDs have been on the rise for a long time.
Noncommunicable diseases such as cancer, cardiovascular diseases, chronic respiratory diseases and diabetes present one of the most serious health challenges in advanced economies. This paper explores how fast-moving consumer goods companies (FMCGs) in Switzerland can contribute to better alternatives for a better tomorrow for consumers.
What causes this burden on quality of life and healthcare costs, and have all options been explored to reduce NCDs?
The key take-aways are:
Learn more and download the study here:
You can read the study in French here.